David Greenspan’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$880K Hold
704,118
– – 0.01% 43
2026
Q2
$1.34M Hold
704,118
– – 0.02% 39
2026
Q1
$2.24M Hold
704,118
– – 0.03% 42
2025
Q4
$3.03M Hold
704,118
– – 0.04% 49
2025
Q3
$27.4M Hold
704,118
– – 0.42% 43
2025
Q2
$16.4M Buy
+704,118
New +$16.6M 0.28% 37

Other funds holding TVRD

David Greenspan's TVRD Position: Q3 2026 in Review

David Greenspan held its Tvardi Therapeutics (TVRD) position steady in Q3 2026 at 704,118 shares worth $880K. The position accounts for 0.01% of the portfolio, ranked #43.

David Greenspan first reported a position in TVRD in Q2 2025 and has held it in 6 quarters since. The position peaked at $27.4M in Q3 2025. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.

  • David Greenspan held 704,118 shares of Tvardi Therapeutics worth $880K as of Q3 2026.
  • David Greenspan left its Tvardi Therapeutics share count unchanged in Q3 2026.
  • Tvardi Therapeutics made up 0.01% of David Greenspan's portfolio in Q3 2026, its #43 holding.
  • David Greenspan first reported a position in Tvardi Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • David Greenspan's Tvardi Therapeutics position peaked at $27.4M in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.

Based on Slate Path Capital's 13F filing for Q3 2026, filed 16 Nov 2026.